News

Chicago-based Level Ex has received an undisclosed investment from OSF Ventures, the investment arm of Peoria, Illinois-based 13-hospital system OSF HealthCare.

A study published in JAMA Internal Medicine today demonstrated that a smartphone app could lead to small improvements in self-reported medication adherence among participants with poorly controlled hypertension.

Last quarter, the Department of Health and Human Services and the Department of Veterans Affairs have both continued to seek public and private partnerships and investigate new technology.

Pharma companies have been eying digital health with interest, and the first quarter of 2018 was no exception.

Through a mix of studies, pilots, and deployments, the first quarter of 2018 saw a lot of providers moving deeper into digital health.

Cambridge, Massachusetts-based Common Sensing, which specializes in connected containers for injectable medications, has raised $6.

Brisbane, Australia-based ResApp Health, a digital health company that specializes in diagnosing respiratory diseases, is now conducting clinical proof-of-concept studies for its latest technology that uses a smartphone to detects sleep apnea by sound.

Lending an ear.

Personal genomics company Helix announced two new partnerships this week, both of which take the company — which has focused on ancestry and lifestyle applications in the past — strongly into the clinical realm.

Dr Robert Wachter, Professor and Chair of the Department of Medicine at the University of California, San Francisco, will be speaking at the HIMSS Europe & Health 2.0 conference in May in Sitges, Spain, supported by the Dutch Ministry of Health.